The Effect of Male Hormonal Contraceptive Regimens on Prostate Tissue In Normal Men

Trial Profile

The Effect of Male Hormonal Contraceptive Regimens on Prostate Tissue In Normal Men

Completed
Phase of Trial: Phase II/III

Latest Information Update: 14 Nov 2013

At a glance

  • Drugs Dutasteride; Medroxyprogesterone; Testosterone
  • Indications Alopecia; Benign prostatic hyperplasia; Prostate cancer; Prostatic intraepithelial neoplasia
  • Focus Pharmacodynamics
  • Acronyms PROS-1
  • Most Recent Events

    • 03 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 02 Feb 2010 Planned end date changed from 1 Jan 2010 to 1 Jan 2012 as reported by ClinicalTrials.gov.
    • 08 Jan 2009 Actual initiation date (Jan 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top